Correlation between Age, IPSS, Prostate size with histopathological findings and management of patients of prostatism
Main Article Content
Abstract
Introduction: Benign prostatic obstruction/enlargement (BPO/BPE) is one of the important aetiology for Bladder outlet obstruction (BOO) in men. Study has been planned to measure various parameters of bladder dysfunction by using Cystometry in patients of Prostatism and to find out correlation between various parameters like age, prostate size, IPSS, management of patients with Prostatism, choice of operative procedure performed and various histopathological findings. Methods: This was observational study. Total 75 patients with age> 50 year and IPSS > 19 having symptoms of Prostatism were included in the study. Patient detailed history was taken and demographic parameters with IPSS, histopathological findings, management plan, Ultrasonography findings were recorded in structured proforma. Results: It is seen that the maximum i.e. 39 (52%) cases of prostatism are observed in the age group of 60 to 70 years. The average age was 67.29 years. Maximum i.e. 31 (41.33%) cases of prostatism had prostate size in 50-70 gms.36 patients were managed by catheterisation while surgery was performed in remaining 39 patients. Transurethral resection of prostate (TURP) was performed in 36 of 39 patients. IPSS was decreased significantly from average of 26 to average of 22 after 2 weeks of operation/catheterisation. Conclusion: Prevalence of BPE increases with age as there found to be positive correlation between age and Prostate size. TURP was preferred procedure in our tertiary centre for the treatment of BPE. Significant decrease in IPPS suggests improvement in symptoms of BPE after operation/catheterisation.
Keywords: Bladder outlet obstruction; Prostatism; International Prostate Symptom Score; Transurethral resection.
Article Details
Section
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
References
Abrams P. New words for old: lower urinary tract symptoms for “prostatism.†BMJ. 1994; 308: 929-930.
Hines JEW. Symptom indices in bladder outlet obstruction. BJU 1996;77:494-1.
Cockett ATK, Aso Y, Chatelain C. The international consultation on benign prostatic hyperplasia, Paris 1991. Jersey: Scientific International. 1991.
Victor W. Nitti. Pressure Flow Urodynamic Studies: The Gold Standard for Diagnosing Bladder Outlet Obstruction. [Rev Urol. 2005;7(suppl 6):S14-S21]
Jonler M, Riechmann M, Bruskewitz RC. Benign prostatic hyperplasia. Current pharmaceutical treatment. Drugs 1994;47:66-8
JEREMY L. OCKRIM, MARC E. LANIADO, ANUP PATEL, ANDREA TUBARO AND SIMON ST CLAIR CARTER. Probability based system for combining simple office parameters as a predictor of bladder outlet obstruction.J.Urology.2001;166:2221-2225
WPJ Witjes RG Aarnink H Wijkstra . The correlation between prostate volume, transition zone volume, transition zone index and clinical and urodynamic investigations in patients with lower urinary tract symptoms.Brit.Jour.Urol.1997; 80:84-90.
Berry SJ, Coffey DS, Walsh PC. The development of BPH with age. J Urol 1984;132:474-9
Oranusi CK, Nwofor AE, Mbonu O. Correlation between international prostate symptom score and uroflowmetry in patients with benign prostatic hyperplasia. Niger J Clin Pract 2017;20: 454-8.
Poul C. Frimodt Peter Iverson Paul O Madsen. Analysis of symptoms in prostatism. Jour. of Urology.2004;152:272-275